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CD70 Is Selectively Expressed on Th1 but Not on Th2
Cells and Is Required for Th1-Type Immune Responses
Tatsuyoshi Kawamura1, Youichi Ogawa1, Osamu Shimozato2,4, Takashi Ando3, Atsuhito Nakao3,
Tetsuji Kobata2,5, Ko Okumura2, Hideo Yagita2 and Shinji Shimada1
The interaction between CD27 and CD70 provides a costimulatory signal for T-cell survival. Although the role
of CD27 signaling in CD8þ T cells has been well defined, its role in CD4þ T cells is relatively unknown. Here, we
report that CD70 is specifically expressed on differentiated T-helper (Th)1 cells, but not on Th2 cells. Upon
activation, CD70 expression increased markedly on Th1 cells, but remained undetectable on Th2 cells. We
demonstrate that CD27 is involved in naive T-cell expansion in Th1-type, but not in Th2-type, immune responses
as in vivo treatment with anti-CD70 monoclonal antibody at induction resulted in a significant reduction of
delayed-type and contact hypersensitivity responses, but not asthmatic responses. In both Th1-type responses,
during the priming phase, CD70 was detected at earlier time points on dendritic cells (DCs) and at later time
points on CD4þ T cells. Our results indicate that CD70 may be useful as a marker to distinguish Th1 from
Th2 cells. More importantly, CD27 function may be controlled by the differentially regulated kinetics of CD70
expression on DCs and CD4þ T cells, and Th1 cell-specific CD70 expression may be involved in an amplification
loop for polarized Th1-type immune responses through T cell–T cell interactions.
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INTRODUCTION
CD27 is expressed on thymocytes, as well as on naive CD4þ
and CD8þ T cells (Borst et al., 2005; Watts, 2005; Nolte et al.,
2009). Its unique ligand CD70 is transiently expressed on
activated T cells, B cells, and dendritic cells (DCs), and CD27
function is controlled by a tightly regulated CD70 expression
in vivo (Oshima et al., 1998; Tesselaar et al., 2003; Borst et al.,
2005; Bullock and Yagita, 2005; Watts, 2005; Sanchez et al.,
2007; Nolte et al., 2009). CD27 provides a costimulatory
signal for T cells by supporting the survival of activated T cells
rather than by affecting cell division (Hendriks et al., 2000,
2003; Borst et al., 2005; Peperzak et al., 2010). A number of
studies have examined the costimulatory effect of CD27/CD70
signaling on CD8þ T cells in vivo using viral infection, cardiac
allograft, tumors rejection, and major histocompatibility
complex class I-restricted delayed-type hypersensitivity (DTH)
models, in which CD27 has a critical role for CD8þ T cells in
the accumulation of cytolytic effector cells and in memory
formation (Borst et al., 2005; Watts, 2005; Nolte et al., 2009).
CD4þ T cells can be divided into T-helper type 1 (Th1)
and type 2 (Th2) cells according to distinct profiles of
cytokine production (Abbas et al., 1996; Ho and Glimcher,
2002). Th1 cells produce IFN-g, whereas Th2 cells produce
IL-4, IL-5, and IL-13. Several surface molecules have been
shown to be differentially expressed between Th-cell subsets.
For example, the IL-12 receptor b2 chain, IL-18R, chemokine
receptors CXCR3 and CCR5, Tim-3, and natural killer group 2
molecules are preferentially or selectively expressed on Th1
cells, whereas the T1/ST2, CCR3, CCR4, and inducible T-cell
co-stimulator molecules are mainly found on Th2 cells
(Szabo et al., 1997; D’Ambrosio et al., 1998; Lohning
et al., 1998; Sallusto et al., 1998; Xu et al., 1998; McAdam
et al., 2000; Meyers et al., 2002; Monney et al., 2002).
The role of CD27/CD70 interactions in Th1 and Th2 cell-
mediated immune responses is unclear. CD27/ mice
infected with the influenza virus showed impaired accumula-
tion of both CD4þ T and CD8þ T cells in the lung and
spleen, respectively (Hendriks et al., 2000). However,
no difference in the percentages of IFN-g-producing CD4þ
T cells was observed between CD27/ and CD27þ /þ
mice. Nevertheless, CD27/ mice immunized with the
intranasal ovalbumin (OVA) protein showed decreased
frequency of IFN-g- and IL-2-producing CD4þ T cells (Xiao
et al., 2008). Similarly, B cell-specific CD70 transgenic mice
showed marked increases in the number of CD4þ T cells
that produced more IFN-g but similar levels of IL-2 and
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tumor necrosis factor-a compared with wild-type mice (Arens
et al., 2001). In lymphocytic choriomeningitis virus infection,
CD27 signaling in CD4þ T cells enhanced the secretion of
IFN-g and tumor necrosis factor-a, leading to destruction of the
splenic architecture (Matter et al., 2006). Intriguingly, anti-
CD70 mAb treatment significantly reduced the proinflamma-
tory cytokines IL-6, tumor necrosis factor-a, and IFN-g in an
experimental inflammatory bowel disease model, whereas it
did not affect tumor necrosis factor-a, IFN-g, IL-4, IL-5, or IL-10
production in an experimental allergic conjunctivitis model
(Sumi et al., 2008; Manocha et al., 2009). Thus, it is still
unclear whether CD27/CD70 signaling is involved in CD4þ
T-cell priming, differentiation, or ‘‘polarization’’ in vivo.
In this study, we investigated the expression of CD70
on Th1 and Th2 cells derived from OVA-specific T-cell
receptor transgenic mice, and the contribution of CD70 to
OVA-specific Th1- and Th2-type immune responses in vitro
and in vivo. We further investigated the role of CD27/CD70
signaling in contact hypersensitivity (CHS) by examining the
effect of neutralizing anti-CD70 mAb in vivo.
RESULTS
Expression of CD27 and CD70 on Th1 and Th2 cells
We first examined the expression of CD27 and CD70 on acti-
vated Th1 and Th2 cells. Upon stimulation with ionomycin
plus PMA (phorbol 12-myristate 13-acetate), Th1 and Th2
cell lines produced IFN-g and IL-4, respectively (Figure 1a).
CD27 was expressed on almost all resting Th1 and Th2 cells,
but was partly downregulated by stimulation with immobi-
lized anti-CD3 and anti-CD28 mAbs (Figure 1b). Stimulation
of Th1 cells induced high CD70 expression levels that peaked
at 48–72 hours and then gradually decreased. In contrast,
no significant expression of CD70 was induced on Th2 cells
by the same stimulation (Figure 1c). Similarly, although
CD70 expression was not observed on resting or activated
D10G4 cells, CD70 was expressed on activated 28-4 cells
(Figure 1d). Furthermore, both resting and activated human
Th1 cell line HK-12 cells expressed abundant CD70
(Supplementary Figure S1 online).
Engagement of CD27 increases the proliferation and cytokine
production of naive CD4þ T cells, but not of Th1 or Th2 cells
To examine the costimulatory function of CD27, naive
CD4þ T cells, Th1 and Th2 cell lines were stimulated with
immobilized anti-CD3 mAb in the presence of coimmobi-
lized anti-CD27 mAb or control IgG. Engagement of CD27 by
anti-CD27 mAb significantly increased the proliferation
and the IFN-g and IL-4 production of naive CD4þ T cells
(Figure 2a), whereas it did not significantly affect the
proliferation or cytokine production of Th1 or Th2 cells
(Figure 2b). To further examine whether CD27/CD70
signaling is involved in T–T cell interactions, naive CD4þ T
cells or Th1 cells were stimulated with immobilized anti-CD3
and anti-CD28 mAb or with immobilized anti-CD3 mAb
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Figure 1. Expression of CD27 and CD70 on Th1 and Th2 cells. (a) Cytoplasmic staining for IFN-g and IL-4. Th1 and Th2 cell lines were stimulated
with PMA plus ionomycin for 24 hours. (b, c) Th1 and Th2 cell lines were stimulated with anti-CD3 and anti-CD28 mAbs for the indicated periods. Cells were
stained with (b) anti-CD27 mAb or with (c) anti-CD70 mAb (solid lines). (d) Murine Th1 (28-4) and Th2 (D10G4) clones were stimulated with anti-CD3
and anti-CD28 mAbs for 48 hours, and then stained with anti-mouse or human CD70 mAb (solid lines). (b–d) Broken lines indicate background staining with
control antibodies. All data are representative of three independent experiments with similar results. PMA, phorbol 12-myristate 13-acetate; Th, T-helper.
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alone, respectively, in the presence of soluble anti-CD70
mAb or control IgG. Although we confirmed that CD70
was induced on naive CD4þ T cells and Th1 cells by
those stimulations (data not shown), no significant differences
between control IgG and anti-CD70 mAb were observed
in terms of naive CD4þ T-cell proliferation (Figure 2d)
or Th1-cell proliferation and IFN-g production (Figure 2c).
However, in the presence of anti-IL-4 mAb, anti-CD70
mAb significantly decreased naive CD4þ T-cell expan-
sion (Figure 2d), suggesting that IL-4 produced by acti-
vated T cells restricts T–T cell interaction by CD70/CD27
signaling.
CD70 is important for OVA-specific T-cell responses
To clarify the role of CD27/CD70 in CD4þ T-cell responses
in vivo, we used a DTH model (Kearney et al., 1994).
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Figure 2. Engagement of CD27 increases the proliferation and cytokine production of naive CD4þ T cells, but not of Th1 or Th2 cells. (a) Naive CD4þ T cells,
(b, upper panels) Th1, or (b, lower panels) Th2 cell lines were stimulated with anti-CD3 mAb in the presence of anti-CD27 mAb (K) or control IgG (J).
(c) Th1 cell lines were stimulated with anti-CD3 mAb in the presence of anti-CD70 mAb (K) or control IgG (J). (d), Naive CD4þ T cells were stimulated with
anti-CD3 and anti-CD28 mAbs in the presence of the indicated mAbs and anti-CD70 mAb (K) or control IgG (J). Cells were assessed for proliferation and production of
IFN-g and/or IL-4. Similar results were obtained in three independent experiments. *Po0.05 compared with the control IgG group. Cont., control; Th, T-helper.
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DO11.10 (KJ1-26þ ) CD4þ T cells were adoptively trans-
ferred into BALB/c mice, and 2 days later, OVA/complete
Freund’s adjuvant (CFA) was injected subcutaneously
(Kearney et al., 1994). Intraperitoneal (i.p.) administration
of anti-CD70 mAb significantly decreased the number of
Ag-specific (KJ1-26þ ) CD4þ draining lymph node (DLN)
T cells at day 6 compared with control Ig-treated mice (Figure
3a). When DO11.10 CD4þ T cells were labeled with
carboxyfluorescein diacetate succinimidyl ester (CFSE) before
adoptive transfer, immunization with OVA/CFA dramatically
induced cell division of KJ1-26þ T cells, which was
manifested by reduced CFSE levels (Figure 3b). Treatment
with anti-CD70 mAb did not affect the cell division in KJ1-
26þ T cells (Figure 3b), whereas it significantly increased
the percentage of apoptotic (annexin Vþ ) cells in KJ1-26þ
T cells as compared with control IgG-treated mice (Figure 3c).
To explore the functional contribution of CD70 to cytokine
production by KJ1-26þ T cells, DLN cells were restimulated
with the OVA323–339 peptide in vitro. Strikingly, both the
frequency of IFN-g-secreting cells and the level of IFN-g
production were significantly reduced in cultures derived
from anti-CD70 mAb-treated mice as compared with control
IgG-treated mice (Figure 3d). These results suggest that the
CD27/CD70 interaction has an important role in supporting
Ag-specific naive CD4þ T-cell expansion by allowing the
primed CD4þ T cells to survive successive divisions in vivo.
We next examined CD70 expression in this model.
The number of CD70þ KJ1-26þ T cells and CD70 mRNA
expression levels in CD4þ T cells were dramatically
increased after primary and secondary immunization with
OVA/CFA (Figure 4a and b). Notably, CD70þ cells were only
detected in the CFSElow KJ1-26þ T-cell fraction, indicating
that cell surface CD70 was expressed on activated T cells
undergoing cell divisions. Interestingly, CD70 expression was
observed on CD4þ T cells 3 days after the first immunization,
whereas its expression on CD11cþ DCs peaked on day 1
(Figure 4c).
To confirm whether CD70 expressed on T cells is
functional, CD4þ T cells were purified from DLN cells
harvested 3 days after immunization, and cultured in the
presence of soluble anti-CD70 mAb or control IgG for 3 days.
As expected, anti-CD70 mAb significantly decreased CD4þ
T-cell expansion (Figure 4d), suggesting that CD70 expressed
on CD4þ T cells is functional in T–T cell interaction.
CD70 is important for the induction of Th1-predominant CHS
To explore the role of CD27/CD70 in Th1-mediated diseases
in vivo, we investigated DNFB-induced CHS. It has been
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shown using CD8/ and CD4/ mice that both CD4þ
Th1 and CD8þ T cells are crucial effector cells in CHS
responses to DNFB (Wang et al., 2000). Interestingly,
treatment with anti-CD70 mAb at sensitization significantly
inhibited ear swelling as compared with control Ig-treated
mice (Figure 5a), whereas treatment at challenge did not
significantly affect ear swelling (Figure 5b). DLN cells
isolated 5 days after DNFB sensitization produced a high
level of IFN-g and a low level of IL-4 in response to DNBS
(2,4-dinitrobenzene-sulfonic acid, a water-soluble analog of
DNFB) restimulation (Figure 5c). The frequency of IFN-g-
secreting cells and the level of IFN-g production were
significantly reduced in cultures derived from mice treated
with anti-CD70 mAb as than in those from control
IgG-treated mice (Figure 5c and d). In contrast, the in vitro
addition of anti-CD70 mAb during DNBS restimulation did
not significantly affect the frequency of IFN-g-producing cells
recovered from DNFB-sensitized mice (Figure 5d). A small
population of CD4þ T cells and CD8þ T cells isolated from
DLNs expressed CD70 (Figure 5e), and CD70 mRNA was
also induced in CD11cþ DCs in DLNs after sensitization
(Figure 5f). Notably, we could not detect significant CD70
expression on Th2, Th17, or regulatory T cells isolated from
DLNs (Supplementary Figure S2 online). These findings
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suggested that CD27/CD70 signaling may support Ag-specific
primed T-cell expansion during the sensitization phase of
the CHS response.
Blockade of the CD70/CD27 interaction did not affect
Th2-mediated asthmatic responses
To clarify the role of CD27/CD70 in Th2-type immune
responses in vivo, we used a murine model of asthma caused
by allergen-specific Th2 cells (Wills-Karp, 1999). As shown
in Figure 6a–c, administration of anti-CD70 mAb did not
significantly affect the serum anti-OVA IgE and IgG1 levels,
Th2 cytokine levels in bronchoalveolar lavage fluid, and
inflammatory cell infiltration around the bronchioles, as
compared with those in control IgG-treated mice. In addition,
when splenic T cells were restimulated with OVA in vitro,
the production of IFN-g, IL-4, and IL-5 was not significantly
inhibited in anti-CD70 mAb-treated mice (Figure 6d). These
results indicate that unlike Th1 responses, the blockade
of CD70 during the induction phase did not affect
the development of asthmatic Th2 responses. Consistent
with these findings, we could not detect significant CD70
expression on CD4þ cells obtained from DLNs and splenic
cells after last immunization with OVA in asthmatic
responses (Figure 6e and f).
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DISCUSSION
We demonstrated that in vivo blockade of CD70/CD27
signaling significantly inhibited antigen-specific naive CD4þ
T-cell expansion and Th1-cell generation, and increased the
number of apoptotic cells in Ag-specific T cells without
affecting cell division (Figure 3). However, we found that
CD27/CD70 signaling was not critically involved in either
[3H]-thymidine incorporation or cytokine production by Th1
or Th2 cells (Figure 2). These findings suggest that CD27
signaling may be required for survival of primed T cells, but
not of polarized Th1 or Th2 cells, and have a critical role
in supporting the survival of Ag-primed T cells during the
induction phase of Th1-type immune responses. This notion is
supported by the fact that inhibitory effects of anti-CD70 mAb
were only observed during the sensitization, but not the
challenge, phase of the Th1- and Tc1-mediated CHS response.
We found that during the DTH response, CD70 expression
on CD4þ T cells was observed 3–6 days after the first
immunization, whereas CD70 expression on DCs peaked at
1 day after immunization (Figure 4). Similarly, during the
CHS response, abundant CD70 mRNA expression was
observed in T cells at 3 days after sensitization, whereas its
expression rapidly decreased in CD11cþ DCs/Langerhans
cells at day 3 (Figure 5). As it has been reported for both
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Figure 6. Administration of anti-CD70 mAb at sensitization does not affect asthmatic responses. BALB/c mice were immunized with OVA/alum on days 0 and
12, and then challenged with saline or OVA on days 22, 23, and 24. Control IgG or anti-CD70 mAb was injected intraperitoneally every 3 days from day 0
to day 18. (a) Twenty-four hours after the last OVA challenge, OVA-specific IgE, IgG1, IgG2a, and IgA serum antibody levels were determined by ELISA.
(b) Cytokine levels in the BALF were measured by ELISA. (c) Histological examination of the lungs by H–E staining. Scale bar¼ 2mm. (d) Splenocytes from
sensitized mice treated with either control IgG or anti-CD70 mAb were stimulated with OVA in vitro. Cytokine levels in the supernatants were measured by ELISA.
P-value: compared with the control IgG group. (e, f) DLN (e) and splenic (f) cells obtained 0, 1, and 3 days after the last immunization were stained with anti-
CD70 and anti-CD4 mAb. Data showing the staining of electronically gated CD4þ T cells. Data are representative of several experiments with similar results.
alum, aluminum hydroxide; BALF, bronchoalveolar lavage fluid; Cont., control; DLN, draining lymph node; H–E, hematoxylin and eosin; OVA, ovalbumin.
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responses that Ag-bearing DCs and Langerhans cells rapidly
disappear from the DLN 48–72 hours after immunization
(Ingulli et al., 1997; Kawamura et al., 1999), it is possible that
the rapid loss of CD70 on DCs/Langerhans cells, probably
induced by interaction with CD40L-expressing CD4þ T cells
(Taraban et al., 2004; French et al., 2007), may be due to
the disappearance of these cells from the DLN. In humans,
a direct cellular communication between CD45ROþ and
CD45RAþ T cells through CD27/CD70 has been proposed
(Agematsu et al., 1995). It is possible that CD70 expressed on
Th1 cells contributes to an amplification loop of polarized
Th1-type immune responses through Th1 cell-naive T-cell
interactions. Indeed, we found that in the absence of IL-4,
blockade of CD27/CD70 signaling through T–T cell interac-
tion significantly decreased naive CD4þ T-cell expansion
(Figure 2d). Taken together, the above findings suggest that
the CD27 function is controlled by the differentially regulated
kinetics of CD70 expression on DCs and activated CD4þ
T cells during the priming phase of Th1 immune responses
in vivo. It has been demonstrated that administration of the
recombinant soluble CD70 protein during antigen stimula-
tion resulted in a massive expansion of Ag-specific CD8þ
T cells in vivo (Rowley and Al-Shamkhani, 2004). Moreover,
T cell-specific CD70 transgenic mice infected with the
influenza virus showed enhanced numbers of effector
memory CD4þ T cells in B-cell follicles (Beishuizen et al.,
2009), thus suggesting that like studies in humans (Agematsu
et al., 1995), CD70 expressed on T cells is functional and
provides CD27 signaling in activating CD4þ T cells in vivo.
Nevertheless, these mice in steady state did not show
enhanced effector memory formation of CD4þ T cells,
despite the fact that the expression of Ki-67 was upregulated
in effector memory CD4þ T cells (van Gisbergen et al.,
2009). Although we demonstrated that CD70 expressed on
CD4þ T cells is functional in T–T cell interaction (Figures 2d
and 4d), further studies are required to determine the
functional significance of CD70 on CD4þ T cells in vivo.
In this study, we have shown that blockade of the CD70/
CD27 interaction inhibits Th1-mediated DTH and CHS
responses, but does not affect Th2-mediated asthmatic
responses. We also found that CD70 is expressed on Th1,
but not on Th2, cells and clones, and that IL-4 strongly
suppressed induction of CD70 expression on CD4þ T cells
(Figure 1 and data not shown). In addition, we could detect
ex vivo CD70 expression on CD4þ cells in Th1-mediated
DTH and CHS, but not in Th2-mediated asthmatic responses
(Figures 4, 5 and 6). In this regard, it has been demonstrated
that induction of CD70 expression on human monocyte-
derived DCs by lipopolysaccharide required an absence of
IL-4 (Iwamoto et al., 2005). On the other hand, CD70 on
splenic DEC-205þ DCs is important for the induction of
IL-12-independent IFN-g production by CD4þ T cells in vivo
(Soares et al., 2007), and in the presence of IL-12, CD27
signaling promotes Th1 development in vitro (van Oosterwijk
et al., 2007). Nevertheless, human CD70 expressed on DCs
promotes the development of CD4þ T cells that produce
both Th1 and Th2 cytokines (Hashimoto-Okada et al., 2009).
One possible explanation for the above findings is that IL-4
produced by CD4þ T cells critically restricts CD70 expres-
sion on both DCs and CD4þ T cells in type 2 immune
responses in vivo, and therefore only in the setting of IL-4
paucity (e.g., Th1-type immune responses), CD70/CD27-
mediated DC-T cell or T–T cell interactions have a role in
activating naive CD4þ T cells. This idea may, at least in part,
account for the discordant results in previous reports
regarding in vivo roles of the CD70/CD27 interaction in
various CD4þ T cell-mediated disease models, including
inflammatory bowel disease (Sumi et al., 2008) and experi-
mental allergic conjunctivitis (Manocha et al., 2009) models.
MATERIALS AND METHODS
Animals
Six-week-old female BALB/c and DO11.10 mice were purchased
from Charles River Japan (Atsugi, Japan) and the Jackson Laboratory
(Bar Harbor, ME), respectively. All mice were used in accordance
with the guidelines of the Committee on Animals of Juntendo
University and the University of Yamanashi.
Reagents and antibodies
Ovalbumin, lipopolysaccharide, PMA, ionomycin, and CFA were
purchased from Sigma (St Louis, MO). The cell-permeant fluorescent
dye CFSE was purchased from Molecular Probes (Eugene, OR).
An anti-murine CD70 mAb (FR70, rat IgG2b) was prepared as
described previously (Oshima et al., 1998). The other mAbs were
purchased from BD Pharmingen (San Jose, CA).
Cell lines and tissue culture
Th1 and Th2 cell lines were originated from naive CD4þ T cells
prepared from the spleen or lymph node of OVA-specific TCR-ab
transgenic mice (DO11.10) as described previously (Watanabe
et al., 1997). T-cell clones used were: HK-12 (human Th1 clone
derived from phytohemagglutinin-stimulated peripheral blood lym-
phocyte), 28-4 (murine Th1 clone specific for KLH), and D10G4
(murine Th2 clone, specific for conalbumin). T-cell lines and clones
were maintained in RPMI 1640 medium containing 10% fetal calf
serum, 10mM HEPES, 0.25 mgml1 gentamycine, 2mM L-glutamine
(complete medium), and 50Unitsml1 recombinant human IL-2
(Shionogi, Osaka, Japan). Naive T cells, T-cell lines, and clones were
stimulated with immobilized anti-CD3 mAb (0.01–10mgml1) in the
presence or absence of immobilized control IgG or mAbs
(10 mgml1) against CD28 and CD27 or with PMA (50 ngml1) plus
ionomycin (500 ngml1).
OVA-specific DTH responses and mAb treatment in vivo
DO11.10 T cells were identified by staining with KJ1-26 mAb
(Caltag, Burlingame, CA) and prepared for adoptive transfer as
described previously (Kearney et al., 1994). In brief, transgenic
lymph nodes and spleen cells depleted of CD8þ T cells were
adoptively transferred by intravenous injection into BALB/c mice
such that 2 106 KJ1-26þ T cells were given to each recipient. Mice
were injected subcutaneously with 100 mg OVA emulsified in CFA
(upper and lower back) 2 days later. Groups of five mice received
i.p. injection of 250mg per mouse anti-CD70 mAb or control IgG
2hours before and 48 hours after immunization. In some experi-
ments, DO11.10 T cells were stained with 2.5 mM CFSE before
adoptive transfer. To determine cytokine production, 4 106 DLN
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cells collected 6 days after immunization were cultured in the
presence of 0–10 mgml1 OVA323–339 peptide for 48 hours.
Contact hypersensitivity
A volume of 20ml of 0.5% DNFB dissolved in acetone:olive oil (4:1)
was painted on the shaved abdomen of mice at days 0 and 1, and then
the ears of mice were challenged with 10ml of 0.2% DNFB
on day 5. Ear thickness was measured as described previously (Nuriya
et al., 2001). Groups of five mice received i.p. injection of 250mg per
mouse anti-CD70mAb or control IgG 2hours before and 48hours after
sensitization or 2hours before challenge. To determine cytokine
production, DLN cells collected from mice 5 days after sensitization or
challenge were incubated with 10mM DNBS (Tokyo Kasei, Tokyo,
Japan) or 0.3mgml1 FITC (isomer-I, Dojindo, Kumamoto, Japan) for
10minutes as described previously (Nuriya et al., 2001).
Induction of allergic airway inflammation and mAb treatment
in vivo
Groups of five mice were sensitized by i.p. injection of 50 mg OVA
with 1mg aluminum hydroxide (alum) on days 0 and 12. On days
22, 23, and 24, mice received intranasal challenges of either 20ml of
saline or 20 ml of saline containing 100mg of OVA. Twenty-four
hours after the last OVA challenge, the trachea was cannulated with
a polyethylene tube through which the lungs were gently lavaged
with 0.8ml phosphate-buffered saline containing 0.1% BSA three
times (2.4ml total of bronchoalveolar lavage fluid). On day 25,
OVA-specific IgE, IgG1, IgG2a, and IgA serum antibody levels were
determined by ELISA (Hoshino et al., 2003). The lungs were
removed from mice 24 hours after the last OVA challenge, fixed in
10% neutral-buffered formalin, and embedded in paraffin. Sections
of 5-mm thickness were stained with hematoxylin and eosin.
To determine cytokine production, splenocytes collected on day
25 were incubated with OVA (100mgml1) for 72 hours. To examine
the effect of anti-CD70 mAb, mice were i.p. injected with 300 mg of
anti-CD70 mAb or control IgG every 3 days from day 0 to day 18.
Real-time PCR
CD4þ T cells, CD8þ T cells, and DCs were positively selected from
DLN cells using anti-CD4, anti-CD8, and anti-CD11c magnetic beads,
respectively, and MACS columns (Militenyi Biotec, San Diego, CA).
Relative CD70 mRNA expression was determined by real-time PCR
using an ABI PRISM 5500 Sequence Detection System (Applied
Biosystems, Framingham, MA) with SYBR Green I dye (Qiagen, Tokyo,
Japan). Total RNA was isolated using TRIzol (Invitrogen Life
Technologies, Carlsbad, CA), and cDNA was synthesized using the
SuperScript system (Invitrogen Life Technologies). Primers correspond-
ing to mouse CD70 and G3PDH were designed by Takara Bio (Shiga,
Japan) as follows: 50-AGCGGACTACTCAGTAAGCAGCAAC-30 and
50-CAGCTCTGGTCCGTGTGTGAA-30 for CD70, and 50-AAATGGT-
GAAGGTCGGTGTG-30 and 50-TGAAGGGGTCGTTGATGG-30 for
G3PDH. Cycle threshold numbers (Ct) were derived from the expo-
nential phase of PCR amplification. Fold differences in the expression
of gene x in the cell populations y and z were derived by 2k, where
k¼ (CtxCtG3PDH)y(CtxCtG3PDH)z.
Flow cytometry
Cells (5 105) were stained with the indicated mAbs (10mgml1) for
30minutes at 41C and analyzed on a FACSCalibur (Becton Dickinson,
San Jose, CA). FITC-labeled annexin V (R&D Systems, Minneapolis,
MN) was used for detection of apoptosis. To assess intracellular
cytokine production, cells were surface stained, fixed and permeabi-
lized, and then stained intracellularly for IFN-g, IL-4, and IL-17.
In vitro proliferation and cytokine assays
Naive CD4 T cells, Th1, and Th2 cells stimulated as described above
were cultured for 72–96 hours and the proliferative response was
measured by [3H]-thymidine (3H-TdR) uptake (0.5mCi per well)
for the last 16 hours. Cell-free culture supernatants and cells were
assayed using cytokine-specific ELISA and ELISPOT assay kits,
respectively (R&D Systems).
Statistical analyses
Significant differences between experimental groups were analyzed
by Student’s t-test. P-values o0.05 were considered significant.
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